The Clinical Utility of Salivary Biomarkers in the Identification of Type 2 Diabetes Risk and Metabolic Syndrome
Priya Desai, Lorin Donovan, Elizabeth Janowitz, Joon Young Kim Department of Exercise Science, Syracuse University, Syracuse, NY, USACorrespondence: Joon Young KimDepartment of Exercise Science, Syracuse University, Women’s Building 204E, 820 Comstock Ave, Syracuse, NY 13244, USATel +1 315...
Guardado en:
Autores principales: | Desai P, Donovan L, Janowitz E, Kim JY |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1781a75b111e423d9f99af05731c632e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Using Salivary Biomarkers for Stress Assessment in Offshore Saturation Diving: A Pilot Study
por: Roxane Monnoyer, et al.
Publicado: (2021) -
The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial
por: LeBaron TW, et al.
Publicado: (2020) -
Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers
por: Zahran AM, et al.
Publicado: (2019) -
Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020) -
Clinical utility of metabolic syndrome severity scores: considerations for practitioners
por: DeBoer MD, et al.
Publicado: (2017)